SCHEMBL18874055

SCHEMBL18874055

N#Cc1ccc(NC2(C(=O)O)Cc3ccccc3C2)cc1NCCc1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.38
▸ CHEK1 O14757 1/20 0.38
▸ HIF1A Q16665 1/20 0.37
▸ HTR2A P28223 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CXCR5 P32302 3/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.33
▸ TAS2R14 Q9NYV8 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ PAX8 Q06710 1/20 0.32
▸ KLF5 Q13887 1/20 0.32
▸ GRM4 Q14833 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1561300 0.85 CXCR5 (0.42) NAMPTHIF1AHTR2ACXCR5NPC1
SCHEMBL18874315 0.73 LMNA (0.42) NAMPTMAPTCXCR5ALDH1A1
SCHEMBL1561717 0.67 LPAR1 (0.56) CXCR5NPC1RAB9A
SCHEMBL18874194 0.62 LPAR1 (0.60) ALDH1A1NPC1RAB9AGRM4
SCHEMBL3903026 0.62 TAAR1 (0.62) MAPTCNR1ALDH1A1GPR84CYP2D6
SCHEMBL22769148 0.61 IDO1 (0.47) ALDH1A1AR
SCHEMBL18874332 0.60 CXCR5 (0.39) MAPTCXCR5ALDH1A1RAB9A
SCHEMBL18874051 0.59 KMT2A (0.58) MAPTALDH1A1RAB9A
SCHEMBL18874328 0.59 CXCR5 (0.47) HTR2AMAPTCXCR5ALDH1A1NPC1
SCHEMBL18873897 0.59 KDM4E (0.47) NAMPTHTR2ACXCR5ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303270-B1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-05-17 — — EP disclosed
Send feedback